TY - JOUR
T1 - Optogenetic control of airway cholinergic neurons in vivo
AU - Pincus, Alexandra B.
AU - Adhikary, Sweta
AU - Lebold, Katherine M.
AU - Fryer, Allison D.
AU - Jacoby, David B.
N1 - Funding Information:
Supported by National Institutes of Health, National Heart, Lung, and Blood Institute grants R01HL124165, R01HL144008, R01HL131525, F30HL145906, and T32HL083808, as well as National Institute of Drug Abuse grants R01DA004523, R01DA008163, R01DA042779, and R21DA048136.
Publisher Copyright:
Copyright © 2020 by the American Thoracic Society.
PY - 2020
Y1 - 2020
N2 - Dysregulation of airway nerves leads to airway hyperreactivity, a hallmark of asthma. Although changes to nerve density and phenotype have been described in asthma, the relevance of these changes to nerve function has not been investigated due to anatomical limitations where afferent and efferent nerves run in the same nerve trunk, making it difficult to assess their independent contributions. We developed a unique and accessible system to activate specific airway nerves to investigate their function in mouse models of airway disease. We describe a method to specifically activate cholinergic neurons using light, resulting in immediate, measurable increases in airway inflation pressure and decreases in heart rate. Expression of light-activated channelrhodopsin 2 in these neurons is governed by Cre expression under the endogenous choline acetyltransferase promoter, and we describe a method to decrease variability in channelrhodopsin expression in future experiments. Optogenetic activation of specific subsets of airway neurons will be useful for studying the functional relevance of other observed changes, such as changes to nerve morphology and protein expression, across many airway diseases, and may be used to study the function of subpopulations of autonomic neurons in lungs and other organs.
AB - Dysregulation of airway nerves leads to airway hyperreactivity, a hallmark of asthma. Although changes to nerve density and phenotype have been described in asthma, the relevance of these changes to nerve function has not been investigated due to anatomical limitations where afferent and efferent nerves run in the same nerve trunk, making it difficult to assess their independent contributions. We developed a unique and accessible system to activate specific airway nerves to investigate their function in mouse models of airway disease. We describe a method to specifically activate cholinergic neurons using light, resulting in immediate, measurable increases in airway inflation pressure and decreases in heart rate. Expression of light-activated channelrhodopsin 2 in these neurons is governed by Cre expression under the endogenous choline acetyltransferase promoter, and we describe a method to decrease variability in channelrhodopsin expression in future experiments. Optogenetic activation of specific subsets of airway neurons will be useful for studying the functional relevance of other observed changes, such as changes to nerve morphology and protein expression, across many airway diseases, and may be used to study the function of subpopulations of autonomic neurons in lungs and other organs.
KW - Cre
KW - Electrophysiology
KW - Optogenetics
KW - Parasympathetic
KW - Peripheral nervous system
UR - http://www.scopus.com/inward/record.url?scp=85082799927&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082799927&partnerID=8YFLogxK
U2 - 10.1165/rcmb.2019-0378MA
DO - 10.1165/rcmb.2019-0378MA
M3 - Article
C2 - 31899655
AN - SCOPUS:85082799927
SN - 1044-1549
VL - 62
SP - 423
EP - 429
JO - American Journal of Respiratory Cell and Molecular Biology
JF - American Journal of Respiratory Cell and Molecular Biology
IS - 4
ER -